News About the Blues? The Power of Placebo

Phillips, Barbara A.
February 2010
Internal Medicine Alert;2/15/2010, Vol. 32 Issue 3, p17
While antidepressants are clearly effective in patients with severe depression, their effects on those with mild or moderate depression may be insignificant.


Related Articles

  • Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data. Sakurai, Hitoshi; Suzuki, Takefumi; Yoshimura, Kimio; Mimura, Masaru; Uchida, Hiroyuki // Psychopharmacology;Aug2017, Vol. 234 Issue 16, p2453 

    Background: Residual symptoms are detrimental to prognosis in major depressive disorder (MDD); however, little is known about the contribution of each residual symptom in predicting outcomes. The objective of this analysis was to identify which individual symptoms, based on self-report and...

  • THE MAP: INTEGRATING INTEGRATIVE MEDICINE. Hyman, Mark A. // Alternative Therapies in Health & Medicine;Jan/Feb2009, Vol. 15 Issue 1, p20 

    The article focuses on functional medicine as a way to integrate integrative medicine. It mentions the various treatments for depression depending on the health practitioner being consulted. Integrative medicine is said to have become a way for healthcare providers who are trained conventionally...

  • Determining when to change to a different antidepressant. Huffman, Grace Brooke // American Family Physician;2/15/1997, Vol. 55 Issue 3, p947 

    Focuses on a study by F.M. Quitkin, et al, published in the `Archives of General Psychiatry,' which tries to determine when patients should be considered unresponsive to antidepressant therapy and should have their treatment changed. `Chronological milestones to guide drug change. When should...

  • New antidepressant drugs called major treatment advances.  // Executive Health's Good Health Report;Oct93, Vol. 30 Issue 1, p3 

    Reports on the acknowledgement of antidepressant drugs Zoloft and Paxil as improvements over previously available antidepressants. Selective serotonin reuptake inhibitors; Effectiveness in treating obsessive compulsive disorders, hypochondriasis and anorexia nervosa; Testing on impulsive behavior.

  • Focus on mirtazapine: A new antidepressant with noradrenergic and specific serotonergic activity. Kehoe, William A.; Schorr, Robert B. // Formulary;Jun96, Vol. 31 Issue 6, p455 

    Focuses on the antidepressant mirtazapine. Chemistry and pharmacology; Serotonic receptors and possible therapeutic applications; Pharmacokinetics; Clinical trials; Adverse effects; Drug interactions; Formulary considerations; Dose and administration. INSET: Formulary considerations..

  • The power of Prozac. Rust, Michael // Insight on the News;09/14/98, Vol. 14 Issue 34, p16 

    Presents information on the antidepressant Prozac. Annual cost of antidepressants in the United States as a result of early death, lost workdays and lowered productivity; Details on Prozac; Investigations being conducted by the Food and Drug Administration on the effort of antidepressants and...

  • Half of antidepressants' benefit attributed to placebo effect.  // Executive Health's Good Health Report;Nov96, Vol. 33 Issue 2, p8 

    Reports that 50 percent of an antidepressant medication's effect can be attributed to the placebo response according to a study made by Doctor Guy Sapirstein from the University of Connecticut. Result of 25 ears' analysis of 3,250 patients with depression.

  • Easy does it. Breu, Joe // Drug Topics;6/24/96, Vol. 140 Issue 12, p37 

    Reports on the Food and Drug Administration's approval of the drug Paxil or paroxetine hydrochloride indicated for panic disorders. Manufacturer; Components; Dosage forms.

  • Vilazodone Hydrochloride Tablets (Viibryd). Elliott, William T.; Chan, James // Internal Medicine Alert;3/15/2011, Vol. 33 Issue 5, p37 

    The article focuses on the introduction of a new antidepressant which had been approved by the Food and Drug Administration (FDA), the Vilazodone or Viibryd in the U.S.

  • Prozac & your libido.  // Joe Weider's Muscle & Fitness;Apr98, Vol. 59 Issue 4, p34 

    Focuses on the effects of taking the antidepressant, Prozac. Classification of Prozac; Identification of symptoms associated with the taking of Prozac; What was noted by J. Raymond Depaulo, a Johns Hopkins psychiatrist.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics